Male vaccination against HPV is safe and effective with regard to immunogenicity in young males. Cost effectiveness and decreased male morbidity and mortality secondary to vaccination require further research before definitive conclusions can be drawn.
The information provided in this handout does not necessarily reflect the views of the University of Minnesota Medical School physicians and faculty. These materials are provided for informational purposes only and are in no way intended to take the place of the advice and recommendations of your personal health care provider. You use the information provided in these handouts at your own risk.
Fowler, Jason Dean.
Male HPV Vaccination.
Retrieved from the University of Minnesota Digital Conservancy,
Content distributed via the University of Minnesota's Digital Conservancy may be subject to additional license and use restrictions applied by the depositor.